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Abstract
Background: We aimed to review the literature regarding the epidemiology of constipation in
Europe and Oceania and the associated prevalence/risk factors.
Methods: Two reviewers performed PubMed searches and a hand search of references. A study
was considered eligible for inclusion if it reported data about the prevalence of constipation in any
population, free of other gastrointestinal disorders, in Europe and Oceania. Studies were evaluated
for quality. Data regarding the setting, type of study, definition of constipation, study population,
prevalence of constipation, factors associated with increased odds for constipation, and the female
to male ratio, were collected.
Results: The 21 reviewed studies depict prevalence rates in 34 different population groups ranging
widely from a low 0.7% to a high 81%. In the general population of Europe the mean value of the
reported constipation rates is 17,1 % and the median value 16.6%. Among the studies conducted
in Oceania, the mean value of constipation prevalence was 15.3%. Female gender, age and
socioeconomic and educational class seem to have major effect on constipation prevalence. A
number of various other risk factors are, less clearly, associated with constipation.
Conclusion: This systematic review depicts the high prevalence and related risk factors of a
disorder that decreases the health-related quality of life and has major economic consequences.
Background
Gastrointestinal functional disorders and especially con-
stipation are common morbidity factors in otherwise
healthy persons as well as in patients with various predis-
posing diseases. In the general population, constipation is
frequently reported, resulting in 2.5 millions of physician
visits in the United States [1] and a total health care cost
of $2752 per patient treated [2]. The high prevalence rates,
economic cost and adverse implications on the quality of
life and health state [3,4], make constipation a major pub-
lic health issue.
Constipation is due to organic etiologies, such as mechan-
ical obstruction, spinal cord injury [5], stroke, Parkinson's
disease, hypothyroidism, diabetes [6] and local neuro-
genic disorders, e.g. Hirschsprung's disease [7] only for a
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minority of patients. The majority of cases are attributed
to functional disorders without a structural underlying
cause that could explain symptoms. Risk factors, such as
dietary habits, physical inactivity [8], socioeconomic
level, psychological parameters, medications [9], age [10],
gender [11], etc have been implicated in the development
of chronic functional constipation. However, the specific
etiology of this gastrointestinal disorder has not been elu-
cidated.
Only a small proportion of patients suffering from consti-
pation seek medical advice; thus, the exact prevalence of
the disorder is difficult to be estimated. A systematic
review of studies on the epidemiology of constipation in
North America [12] recorded various prevalence rates
from a low 1.9% to a high 27.2%. However, most of the
included studies, report rates between 12% and 19%. To
our knowledge, no previous report of the current evidence
has systematically reviewed the epidemiology of constipa-
tion in Europe or Oceania.
We sought to review the literature regarding the epidemi-
ology of functional constipation in Europe and Oceania.
Specifically, our purpose was to identify the prevalence of
constipation in the general population and in special pop-
ulation groups, identify the risk factors associated with
this functional disorder and compare the findings with
those of the systematic review of the epidemiology of con-
stipation in North America [12].
Methods
We performed a systematic review of the current evidence
regarding the prevalence of constipation in Europe and
Oceania. Two reviewers (EGM and VGA) having a medical
degree searched the PubMed database (until December
2006) to identify relevant studies for inclusion. The key
word used in the literature search was "constipation"
combined with "incidence, prevalence, rate, proportion,
epidemiology, or morbidity". Studies were limited to
those written in English, French and referring to humans.
The titles and abstracts of all studies identified were fur-
ther reviewed to meet the entry criteria. Moreover, we per-
formed a hand search of the references of the selected
studies to identify potentially overlooked articles.
A study was considered eligible for inclusion if it reported
data about the prevalence of constipation in any popula-
tion, free of other gastrointestinal disorders, in Europe
and Oceania. All studies involving cases of functional con-
stipation, regardless the diagnostic criteria used were con-
sidered for inclusion. The diagnostic criteria range widely
from self-report and parent-report for children, to consen-
sus criteria like Rome II criteria [13]; at least 12 weeks,
which need not be consecutive, in the preceding 12
months, of two or more of: < 3 defecations per week
(DPW), hard or lumpy stools in > 1/4 of defecations,
straining in > 1/4, digital manipulation of stools in > 1/4,
sensation of incomplete evacuation in > 1/4, sensation of
anorectal obstruction or blockage in > 1/4.
Two of the authors (EM and VGA) retrieved and studied
in detail the complete texts of the original articles that
were relevant to the focus of our review. Agreement
between the investigators was essential for data inclusion
and few minor disagreements were resolved with the con-
sent of the senior author. Data regarding the first author,
year of publication, setting, type of study, definition of
constipation, study population, prevalence of constipa-
tion, factors associated with increased odds for constipa-
tion, and the female to male ratio, were extracted. The
above were tabulated in detail without taking into consid-
eration the differences in methodology among the
reviewed studies. We calculated the mean values for prev-
alence of constipation in Europe and Oceania by averag-
ing the prevalence obtained in each study.
We used the critical appraisal guidelines for research arti-
cles determining prevalence, developed by Loney et al
[14], to evaluate the quality of studies included in our sys-
tematic review. The scoring system consists of 8 questions
on the validity of the study design (appropriate methods
and frame, adequate size, suitable criteria, outcome meas-
urements, and response rate), the interpretation (preva-
lence given with confidence intervals) and the
applicability of the results (detailed description of sub-
jects and settings), weighted equality with one point [15].
Thus the maximum quality score that a study could
achieve was 8.
Results
PubMed database returned a list of 2060 articles for the
selected search string. From these, 2039 reports were
excluded, after having reviewed their titles and abstracts,
based on the criteria outlined in the Methods section. The
full texts of the remaining 21 studies [16-36] were read
and finally included in our systematic review. One more
study [37] was identified following the hand search of ref-
erences. However, Galvez et al evaluated a population
already described by Garrigues et al study (included in this
review). Reviewers disagreed on the inclusion of three
studies [25,26,33]. However, they were included with the
consent of the senior author.
In Tables 1, 2 and 3, we summarize the characteristics
(author, year, type of study, depicted epidemiological
data and quality score) of the reviewed studies regarding
the prevalence of constipation in the general population
of Europe, in special population groups of Europe and in
all population groups of Oceania respectively. Overall the
reviewed studies depict prevalence rates in 34 differentB
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Table 1: Characteristics of studies regarding the epidemiology of constipation in Europe in the general population.
First author, year of 
publication, setting
Type of study Definition of constipation Study population (% of 
responders)
Prevalence per 100 Factors significantly associated 
with increased odds for 
constipation
Quality 
score+
Comments
Siproudhis L 2005 France 
[16]
Mailed questionnaire 
survey
Emptying difficulties or unsatisfied 
defecation during the preceding 12-
month period
7196 (72) persons ≥ 15 yr, 
representative of the general 
population
22.4 History of vaginal delivery in women 6 F/M 2
Garrigues V 2004 Spain 
[17]
Mailed questionnaire 
study
Self-reported, Rome I, and Rome II 
criteria
349 (71.4) participants, 18–65 yr, 
representative of the general 
population
29.5 (self-reported) 19.2 
(Rome I criteria) 14 
(Rome II criteria)
Female gender 7 F/M 2.2 Agreement 
between self-reported and 
Rome II criteria was 
moderate
Walter S 2002 Sweden 
[18]
Mailed questionnaire 
study
Self-reported, as 'sometimes, often 
or always' constipated
1610 (80.5) persons, 31–76 yr, 
randomly selected
19.8 of women 8.3 of men Female gender 4 F/M 2.4
Haug TT 2002 Norway 
[19]
Mailed questionnaire 
study
Self-reported, as 'minor or major 
complaints' during the last 12 
months
62651 (66.5) persons, > 20 yr 20.2 Anxiety, and less strongly depression 4 F/M 4
Frexinos 1998 France 
[20]
Interview- 
questionnaire survey
Self reported 6000 (81) participants > 15 yr, selected 
by systematic random sampling
35 7
Gaburri 1989 Italy 
Umbria [21]
Interview-
questionnaire survey, 
performed by a 
physician.
≤ 2 DPW for > 9 months in the last 
3 years and/or straining at stool > 
75% of the time
544 (98). 104 medical students, 103 
medical and paramedical employees 
and 326 randomly selected home 
interviewed persons.
9.2 Female gender presented significantly 
higher constipation rates.
5
Bassotti G 2004 Italy 
[22]
Prospective study Rome II criteria 298 (61) persons recruited from the 
general population and asked to 
compile a daily diary on their bowel 
habits and associated signs and 
symptoms
5 (< 3 DPW) 
11.7(straining) 
10.7(incomplete 
evacuation)
6
Abbreviations DPW: defecations per week, F/M: female/male ratio, Rome II criteria: at least 12 weeks, which need not be consecutive, in the preceding 12 months, of two or more of: < 3 DPW, hard or lumpy stools in > 1/4 of defecations, 
straining in > 1/4, digital manipulation of stools in > 1/4, sensation of incomplete evacuation in > 1/4, sensation of anorectal obstruction or blockage in > 1/4, +: critical appraisal guidelines for research articles determining prevalence, developed by 
Loney et al14B
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Table 2: Characteristics of studies regarding the epidemiology of constipation in Europe, in special populations groups.
First author, year of 
publication, setting
Type of study Definition of 
constipation
Study population (% of responders) Prevalence per 100 Factors significantly 
associated with increased 
odds for constipation
Quality 
score+
Comments
Lopez Cara MA 2006 Spain 
[23]
Mailed questionnaire survey ≤ 3 DPW 414 (93) participants > 50 yr, selected by systematic 
random sampling
4.4 Consumption of olive oil, and 
meat.
4F / M  2
Kinnunen 1990 Finland [24] Interview-questionnaire survey 
by public health nurse
≤ 3 DPW, difficulties in 
expelling stools because of 
the hardness or anal canal 
abnormalities
5 groups of middle aged and elder population.
1. Hospital: 439
2. Olds people's home: 183
3. Day hospital: 78
4. Home > 74 yrs: 138
5. Home 41–50 yrs: 74
Prevalence per 100 in the 5 
groups
1st: females 79, males 81
2nd: females 57, males 64
3rd: females 30, males 25
4th: females 38, males 37
5th: females 20, males 3
Female gender. Fecal and urinary 
incontinence. Age. Immobility. 
Living in old people's homes and 
geriatric hospital. Age over 84 
years.
5
Bommelaer 1986 France [25] Interview-questionnaire survey, 
performed by a physician.
≤ 3 DPW 1200 participants. Randomized selection among 
healthy medical and para-medical personnel and 
medical students. Statistically tested to assure same 
participation of gender, age and socio-professional 
groups
6.3 Female gender. Use of laxatives. 3 F/M 1.12
Texerau 1989 France [26] Interview-questionnaire survey, 
performed by a 
gastroenterologist.
Self reported 667 participants in 4 groups. 82 medical students, 206 
patients from local health center, 210 adults 
interrogated in an occupational medicine office and 69 
persons from an olds people house.
26 3 F/M 0.96
Chin A Paw M 2006 The 
Netherlands [27]
RCT investigating the effects of 
training on constipation, 
questionnaire study
Defined below* 172 (76.8) participants living in long-term care 
facilities, 64–94 yr
22 5
Ludvigsson JF 2006 Sweden 
[28]
Prospective cohort study, 
questionnaire survey
Reported by parents 8341 (38.4) 2.5-yr-children from a birth cohort 6.5 Low maternal education, female 
sex, living in a large community, 
lack of older siblings
3
Iacono G 2005 Italy [29] Prospective study, data 
obtained from 150 
paediatricians
One bowel movement every 
3 days or more
2879 (96) newborns up to six months of age 17.6 Lower frequency of breastfeeding. 4 F/M 1
Miele E 2004 Italy [30] Prospective study, data 
obtained from 13 randomly 
selected paediatricians
Rome criteria for children 9660 children, 0–12 yr 0.7 5 F/M 1.2
Soligo M 2006 Italy [31] Retrospective survey Decreased stool frequency, 
difficult stool passage
786 consecutive urogynecologic patients, average age 
60 yr
31.7 Posterior colpocele 4
Abbreviations DPW: defecations per week, F/M: female/male ratio, RCT: randomized controlled trial, Rome criteria for children: in infants and preschool children, at least 2 wk of pebble-like, hard stools for a majority of stools, firm stools 2 or fewer 
times per week, and no evidence of structural, endocrine, or metabolic disease, *: at least one of less than three bowel movements weekly, hard or lumpy stools, straining on defecation, incomplete evacuation, in the preceding 12 months +: critical 
appraisal guidelines for research articles determining prevalence, developed by Loney et al14
Table 3: Characteristics of studies regarding the epidemiology of constipation in Oceania.
First author, year of 
publication, setting
Type of study Definition of constipation Study population (% of responders) Prevalence per 100 Factors significantly associated 
with increased odds for 
constipation
Quality 
score+
Comments
Howell SC 2006 Sydney [32] Mailed questionnaire survey Rome II criteria 1673 (42.6) persons, 25–64 yr, randomly 
selected from 28 districts
30.7 Upper-middle educational social 
class. Female gender.
6F / M  1 . 4
Campbell 1992 New Zealand 
[33]
Interview-questionnaire 
survey and a dietary 
assessment
≤ 3 DPW, strained at stools, taking 
laxatives every 2–3 days
856 (91) participants> 70 years registered with 
the five general practitioners serving a rural 
township of 13500 people
4.3 had ≤ 3 DPW 20.3 had 
one of the three factors that 
may indicate constipation
Female gender and age 3 F/M 1.76
Bytzer P 2001 Sydney [34] Mailed questionnaire survey At least one of < 3 DPW, hard or 
lumpy stools, anal blockage, during 
preceding 3 months
8555 (57), divided into 5 socioeconomic 
classes, from 1st (highest) to 5th (lowest) 
quintiles
1st: 6.3
2nd: 8.7
3rd: 9.6
4th: 10.3
5th: 10.2
Low socioeconomic class. 6
Chiarelli P 2000 Australia [35] Questionnaire survey Sometimes or often experiencing 
constipation symptoms during the 
preceding 12 months
14761 (41) women 18–23 yr
14070 (54) women 45–50 yr
12893 (37) women 70–75 yr
14.1 (18–23 yr)
26.6 (45–50 yr)
27.7 (70–75 yr)
Haemorrhoids and 'other bowel 
problems' in all three cohorts. 
Parity in the young cohort. 
Hysterectomy, prolapse repair, and 
medications in the middle-aged and 
older cohorts.
3
Talley NJ 2004 New Zealand 
[36]
Questionnaire survey Defined below* 924 persons 26 yr old, from a birth cohort (94 
of total original sample)
19.9 Female gender. 5 F/M 1.3
Abbreviations DPW: defecations per week, F/M: female/male ratio, Rome II criteria: at least 12 weeks, which need not be consecutive, in the preceding 12 months, of two or more of: < 3 DPW, hard or lumpy stools in > 1/4 of defecations, straining in 
> 1/4, digital manipulation of stools in > 1/4, sensation of incomplete evacuation in > 1/4, sensation of anorectal obstruction or blockage in > 1/4, *: at least one of less than three bowel movements weekly, hard or lumpy stools, straining on defecation, 
incomplete evacuation, in the preceding 12 months, RCT: randomized controlled trial, +: critical appraisal guidelines for research articles determining prevalence, developed by Loney et al14BMC Gastroenterology 2008, 8:5 http://www.biomedcentral.com/1471-230X/8/5
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population groups ranging widely from a low 0.7% in a
pediatric population in Italy [30] to a high 81% in a hos-
pitalized, elderly, male population [24]. The mean value
of the reported constipation rates is 22.3 and the median
value 19.8. More than half of the reported constipation
rates range from 8% to 26%.
Seven studies have data on the prevalence of constipation
in the general population in Europe (Table 1). The
reported constipation rates range from a low 5% in a pro-
spective study using the diagnostic criterion of < 3 defeca-
tions per week (DPW) [22] to a high 35% in an interview
questionnaire survey of self-reported constipation [20].
The mean value of the reported constipation rates is 17.1
% and the median value 16.6%. Nine studies depict con-
stipation prevalence rates in special population groups in
Europe: infants, children, elderly population, women and
participants living in long-term care facilities (Table 2).
Finally, 5 studies regarding the epidemiology of constipa-
tion in Oceania are tabulated in Table 3. The lowest prev-
alence was observed among an elderly population in New
Zealand (4.3%) [33]. Howel et al recorded the highest
prevalence rate of constipation in the general population
of Sydney Australia (30.7%). Among the studies con-
ducted in Oceania, the mean value of constipation preva-
lence is 15.3%.
A secondary purpose of this review was to identify risk fac-
tors related with this functional constipation disorder. In
particular, the predominance of females in the constipa-
tion prevalence is documented in most of the reviewed
studies. In order to depict the exact magnitude of this
association we present in Tables 1, 2 and 3 the female/
male ratio, in the studies where available. The mean and
median value of the above ratio is calculated to 1.78 and
1.58 respectively. There are differences of the female/male
ratio estimates by definition of constipation. However,
the mean value remains above 1 for all case criteria, 1.7 for
Rome I, 1.8 for Rome II, and 2.3 for self-report of consti-
pation.
The effect of ageing on constipation prevalence has been
recorded by 3 of the reviewed studies [24,27,33]. Socioe-
conomic and educational class influence on the constipa-
tion prevalence is also depicted in 3 studies [28,32,34].
Various other risk factors are associated with constipation
by at least one research paper included in our systematic
review of the current evidence; dietary habits like the con-
sumption of olive oil and meat, life-style factors like living
in a large community or old peoples home and immobil-
ity, frequency of breastfeeding, waist/hip ratio, anxiety
and depression, co morbidities like hemorrhoids, other
bowel disorders, previous hysterectomy and posterior col-
pocele and the use of medications like laxatives.
Discussion
The prevalence rates of constipation in Europe and Oce-
ania as depicted by this review are consistent with the epi-
demiology of the disorder in North America [12].
Prevalence rates of constipation recorded in other devel-
oped countries are also within the same range; 14.3% in
the general population in Hong-Kong [38], 16.5% in the
general population in Korea [39], 24.5% in women in Tai-
wan [40], 26% in a population of young women in Japan
[41], 29.6% in young children in Hong Kong [42], and
11.6% in an elderly Asian population [43]. The similarity
of constipation rates recorded in the developed countries
may partially be due to the common dietary habits of the
studied populations. Constipation in individuals with
previously normal bowel function is associated with spe-
cific dietary patterns; low fiber intake diet is involved with
the pathogenesis of the disorder. Europe and Oceania are
similar to North America in terms of health system and
population's dietary habits, life style, physical activity and
socioeconomic level.
Differing case definitions of constipation used, provide
researchers with diverse prevalence rates. This is evident in
the Garrigues et al study, where different diagnostic crite-
ria were compared in the same individuals, resulting in
significant differences in the depicted prevalence rates;
29.5% for self-report, 19.2% for Rome I criteria and 14%
for Rome II criteria. We identified 3 studies using the
Rome II criteria; the mean prevalence rate among these
reports is 16.5%. The relevant mean prevalence rates for
Rome I criteria and self-report are 19.2% and 25.6%
respectively. It should be mentioned that the Rome III
consensus provides the most up to date definition and cat-
egorization of functional gastrointestinal disorders in
children/adolescent [44] and neonate/toddler [45]. None
of the reviewed studies implemented the Rome III criteria.
Future studies on the epidemiology of constipation
should rather be based on consensus diagnostic criteria.
Female gender is associated with elevated constipation
prevalence rates [17,18,21,25,32,33,36]. In North Amer-
ica, females are 2.2 times more likely to report constipa-
tion than males [12]. This predominance of females has
been attributed to hormonal factors, inflicting a higher
risk of constipation during the luteal phase of the men-
strual cycle, under the effect of progesterone, and damage
to the pelvic floor muscles, which may occur in women
during childbirth or gynecological surgery [35]. Posterior
colpocele is an independent risk factor for constipation
[31]; however, causal relationship between these disor-
ders is difficult to be assumed.
In general, individuals of lower social, economic and edu-
cational level have a tendency towards higher constipa-
tion rates. Bytzer et al divided the sample of theirBMC Gastroenterology 2008, 8:5 http://www.biomedcentral.com/1471-230X/8/5
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questionnaire survey into five socioeconomic classes from
1st (highest) to 5th (lowest). They showed that the consti-
pation prevalence rates among those five groups followed
the pattern of their socioeconomic class, ranging from a
low 6.3% for the 1st class to a considerably higher 10.2%
for the 5th class. Of interest, according to another study
[28], low maternal educational level is considered as a fac-
tor significantly associated with increased odds for consti-
pation of the newborn.
Chiarelli et al questionnaire survey compares constipa-
tion prevalence among three age groups, 18–23 years,
45–50 years and 70–75 years and depicts considerable
differences in prevalence rates; 14.1%, 26.6% and 27.7%
respectively. A study focusing on infants followed up for 6
months, showed a prevalence rate of 17.6% [29]. This is
surprisingly high when compared with the constipation
prevalence in a pediatric population aged from 0–12 years
[30]; Miele et al used the Rome criteria in 9960 children
and report a prevalence rate of 0.7%.
Psychological factors and in particular anxiety and depres-
sion, are considered predisposing to constipation [19].
These psychological disorders, as well as obsessive com-
pulsion and social dysfunction, have been implicated in
the pathogenesis of constipation, are believed to slow
down colonic transit, have greater impact on women, and
are associated with less frequent use of coping strategies
[38]. Behavioral treatment, specifically biofeedback, is
alleged to ameliorate the course of the disorder and is fre-
quently used as alternative therapy for persons with symp-
toms unresponsive to traditional medical treatment
[46,47].
Assessing quality in clinical trials is well described but
much less attention has been given to similar strategies for
observational epidemiological studies. We believe that
the quality assessment tool used [14,15] addresses effi-
ciently the need for critical appraisal of prevalence studies.
There were significant differences in the quality and meth-
odology among the reviewed studies. The best score
achieved was 7/8 and the worst 3/8 (Tables 1, 2 and 3).
It should be acknowledge that when interpreting the find-
ings of this systematic review one should take under con-
sideration various limitations and shortcomings. First, the
included studies use different definitions and diagnostic
criteria of constipation, which could lead to inconsisten-
cies regarding the prevalence estimates. No doubt, there is
a discrepancy between self-reported constipation and the
condition diagnosed based on the established Rome crite-
ria. The rates are considerably higher when based on the
definition of self-reported constipation [26]. This discrep-
ancy highlighted by other investigators too [39], may be
due to differences of personal perception regarding the
problem, or could be involved with the validity of criteria.
In addition, the use of questionnaires depends on the
ability of the patient to recall symptoms, whereas prospec-
tive studies with the administration of diary cards are cer-
tainly more credible. Furthermore, the range of age groups
studied is wide, and includes pediatric, as well as elderly
study populations. Finally, it should be acknowledged
that our search of the literature was limited to journals
included in the PubMed database. However, the further
hand search of references reduces possibly omitted stud-
ies. The language limit (articles published in English and
French only) should be attributed to the available human
resources. Despite this limitation, studies from 7 different
European countries were included in our review (Spain,
France, Italy, Netherlands, Norway, Sweden and Finland).
Conclusion
Because of the decrement in the health-related quality of
life induced by constipation, and the economic conse-
quences, physicians should be aware of the magnitude of
the problem, and be able to give efficient instructions to
patients for management, and particularly, prevention.
We believe that our systematic review of current evidence
on constipation provides a useful tool to physicians deal-
ing with this high prevalence clinical problem, and a ref-
erence for future development of studies on the
epidemiology and etiology of the disorder.
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